Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance

Molecular genotype, genetic transmission, and clinical phenotype

Evangelia Charmandari, Tomoshige Kino, Emmanuil Souvatzoglou, Alessandra Vottero, Nisan Bhattacharyya, George P. Chrousos

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Glucocorticoid resistance is a rare, familial, or sporadic condition characterized by partial end-organ insensitivity to glucocorticoids. The clinical spectrum of the condition ranges from completely asymptomatic to severe hyperandrogenism, fatigue, and/or mineralocorticoid excess. The molecular basis of glucocorticoid resistance in several families and sporadic cases has been ascribed to mutations in the human glucocorticoid receptor-α (hGRα) gene, which impair the ability of the receptor to transduce the glucocorticoid signal. We systematically investigated the molecular mechanisms through which natural, ligand-binding domain hGRα mutants, including hGRαI559N, hGRαV571A, hGRαD641V, hGRαV729I, and hGRαI747M, produce a defective signal and determined whether their differential effects on hGRα function might account for the type of genetic transmission of the disorder and the variable clinical phenotype of the affected subjects. Our findings suggest that all five mutant receptors studied have ligand-binding domains with decreased intrinsic transcriptional activity. Unlike hGRαI559N and I747M previously shown to exert a dominant negative effect upon the transcriptional activity of hGRα, hGRαV571A, D641V, and V729I do not have such an effect. All five mutants studied demonstrate varying degrees of decreased affinity for the ligand in a standard dexamethasone binding assay, but preserve their ability to bind DNA. The nondominant negative mutants, hGRαV571A, D641V, and V729I, show delayed translocation into the nucleus after exposure to ligand. Finally, hGRαI559N, V571A, D641V, and V729I display an abnormal interaction with the glucocorticoid receptor-interacting protein-1 coactivator in vitro, as this was previously shown also for hGRαI747M. We conclude that each of the above hGRα mutations imparts different functional defects upon the glucocorticoid signal transduction pathway, which explains the autosomal recessive or dominant transmission of the disorder, but might only explain in part its variable clinical phenotype.

Original languageEnglish
Pages (from-to)1939-1949
Number of pages11
JournalJournal of Clinical Endocrinology and Metabolism
Volume89
Issue number4
DOIs
Publication statusPublished - Apr 2004
Externally publishedYes

Fingerprint

Glucocorticoid Receptors
Glucocorticoids
Molecular Biology
Genotype
Phenotype
Ligands
Nuclear Receptor Coactivator 2
Hyperandrogenism
Signal transduction
Mineralocorticoids
Mutation
Inborn Genetic Diseases
Human Activities
Dexamethasone
Fatigue
Assays
Signal Transduction
Genes
Glucocorticoid Receptor Deficiency
Fatigue of materials

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance : Molecular genotype, genetic transmission, and clinical phenotype. / Charmandari, Evangelia; Kino, Tomoshige; Souvatzoglou, Emmanuil; Vottero, Alessandra; Bhattacharyya, Nisan; Chrousos, George P.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 89, No. 4, 04.2004, p. 1939-1949.

Research output: Contribution to journalArticle

Charmandari, Evangelia ; Kino, Tomoshige ; Souvatzoglou, Emmanuil ; Vottero, Alessandra ; Bhattacharyya, Nisan ; Chrousos, George P. / Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance : Molecular genotype, genetic transmission, and clinical phenotype. In: Journal of Clinical Endocrinology and Metabolism. 2004 ; Vol. 89, No. 4. pp. 1939-1949.
@article{6b877edc7c524c2685216b4d66d996c2,
title = "Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: Molecular genotype, genetic transmission, and clinical phenotype",
abstract = "Glucocorticoid resistance is a rare, familial, or sporadic condition characterized by partial end-organ insensitivity to glucocorticoids. The clinical spectrum of the condition ranges from completely asymptomatic to severe hyperandrogenism, fatigue, and/or mineralocorticoid excess. The molecular basis of glucocorticoid resistance in several families and sporadic cases has been ascribed to mutations in the human glucocorticoid receptor-α (hGRα) gene, which impair the ability of the receptor to transduce the glucocorticoid signal. We systematically investigated the molecular mechanisms through which natural, ligand-binding domain hGRα mutants, including hGRαI559N, hGRαV571A, hGRαD641V, hGRαV729I, and hGRαI747M, produce a defective signal and determined whether their differential effects on hGRα function might account for the type of genetic transmission of the disorder and the variable clinical phenotype of the affected subjects. Our findings suggest that all five mutant receptors studied have ligand-binding domains with decreased intrinsic transcriptional activity. Unlike hGRαI559N and I747M previously shown to exert a dominant negative effect upon the transcriptional activity of hGRα, hGRαV571A, D641V, and V729I do not have such an effect. All five mutants studied demonstrate varying degrees of decreased affinity for the ligand in a standard dexamethasone binding assay, but preserve their ability to bind DNA. The nondominant negative mutants, hGRαV571A, D641V, and V729I, show delayed translocation into the nucleus after exposure to ligand. Finally, hGRαI559N, V571A, D641V, and V729I display an abnormal interaction with the glucocorticoid receptor-interacting protein-1 coactivator in vitro, as this was previously shown also for hGRαI747M. We conclude that each of the above hGRα mutations imparts different functional defects upon the glucocorticoid signal transduction pathway, which explains the autosomal recessive or dominant transmission of the disorder, but might only explain in part its variable clinical phenotype.",
author = "Evangelia Charmandari and Tomoshige Kino and Emmanuil Souvatzoglou and Alessandra Vottero and Nisan Bhattacharyya and Chrousos, {George P.}",
year = "2004",
month = "4",
doi = "10.1210/jc.2003-030450",
language = "English",
volume = "89",
pages = "1939--1949",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance

T2 - Molecular genotype, genetic transmission, and clinical phenotype

AU - Charmandari, Evangelia

AU - Kino, Tomoshige

AU - Souvatzoglou, Emmanuil

AU - Vottero, Alessandra

AU - Bhattacharyya, Nisan

AU - Chrousos, George P.

PY - 2004/4

Y1 - 2004/4

N2 - Glucocorticoid resistance is a rare, familial, or sporadic condition characterized by partial end-organ insensitivity to glucocorticoids. The clinical spectrum of the condition ranges from completely asymptomatic to severe hyperandrogenism, fatigue, and/or mineralocorticoid excess. The molecular basis of glucocorticoid resistance in several families and sporadic cases has been ascribed to mutations in the human glucocorticoid receptor-α (hGRα) gene, which impair the ability of the receptor to transduce the glucocorticoid signal. We systematically investigated the molecular mechanisms through which natural, ligand-binding domain hGRα mutants, including hGRαI559N, hGRαV571A, hGRαD641V, hGRαV729I, and hGRαI747M, produce a defective signal and determined whether their differential effects on hGRα function might account for the type of genetic transmission of the disorder and the variable clinical phenotype of the affected subjects. Our findings suggest that all five mutant receptors studied have ligand-binding domains with decreased intrinsic transcriptional activity. Unlike hGRαI559N and I747M previously shown to exert a dominant negative effect upon the transcriptional activity of hGRα, hGRαV571A, D641V, and V729I do not have such an effect. All five mutants studied demonstrate varying degrees of decreased affinity for the ligand in a standard dexamethasone binding assay, but preserve their ability to bind DNA. The nondominant negative mutants, hGRαV571A, D641V, and V729I, show delayed translocation into the nucleus after exposure to ligand. Finally, hGRαI559N, V571A, D641V, and V729I display an abnormal interaction with the glucocorticoid receptor-interacting protein-1 coactivator in vitro, as this was previously shown also for hGRαI747M. We conclude that each of the above hGRα mutations imparts different functional defects upon the glucocorticoid signal transduction pathway, which explains the autosomal recessive or dominant transmission of the disorder, but might only explain in part its variable clinical phenotype.

AB - Glucocorticoid resistance is a rare, familial, or sporadic condition characterized by partial end-organ insensitivity to glucocorticoids. The clinical spectrum of the condition ranges from completely asymptomatic to severe hyperandrogenism, fatigue, and/or mineralocorticoid excess. The molecular basis of glucocorticoid resistance in several families and sporadic cases has been ascribed to mutations in the human glucocorticoid receptor-α (hGRα) gene, which impair the ability of the receptor to transduce the glucocorticoid signal. We systematically investigated the molecular mechanisms through which natural, ligand-binding domain hGRα mutants, including hGRαI559N, hGRαV571A, hGRαD641V, hGRαV729I, and hGRαI747M, produce a defective signal and determined whether their differential effects on hGRα function might account for the type of genetic transmission of the disorder and the variable clinical phenotype of the affected subjects. Our findings suggest that all five mutant receptors studied have ligand-binding domains with decreased intrinsic transcriptional activity. Unlike hGRαI559N and I747M previously shown to exert a dominant negative effect upon the transcriptional activity of hGRα, hGRαV571A, D641V, and V729I do not have such an effect. All five mutants studied demonstrate varying degrees of decreased affinity for the ligand in a standard dexamethasone binding assay, but preserve their ability to bind DNA. The nondominant negative mutants, hGRαV571A, D641V, and V729I, show delayed translocation into the nucleus after exposure to ligand. Finally, hGRαI559N, V571A, D641V, and V729I display an abnormal interaction with the glucocorticoid receptor-interacting protein-1 coactivator in vitro, as this was previously shown also for hGRαI747M. We conclude that each of the above hGRα mutations imparts different functional defects upon the glucocorticoid signal transduction pathway, which explains the autosomal recessive or dominant transmission of the disorder, but might only explain in part its variable clinical phenotype.

UR - http://www.scopus.com/inward/record.url?scp=1942536210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942536210&partnerID=8YFLogxK

U2 - 10.1210/jc.2003-030450

DO - 10.1210/jc.2003-030450

M3 - Article

VL - 89

SP - 1939

EP - 1949

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -